Clinical trial
Real-World Camzyos Patient Reported OutcoMes Through PAtient SurveyS in Hypertrophic CardioMyopathy (COMPASS-HCM): A Prospective Longitudinal Study
NCT06551129 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Camzyos Patient Reported OutcoMes Through PAtient SurveyS in Hypertrophic CardioMyopathy (COMPASS-HCM): A Prospective Longitudinal Study
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 10, 2024
- Completion date
- June 30, 2027
- Enrollment
- 118 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive hypertrophic cardiomyopathy